1932

Abstract

Mastitis is the most important production disease in dairy farming, leading to considerable inefficiency in production. In 1992, an important paper describing a simple but very useful economic framework for production diseases in animal farming was published. In a systemic literature search, 77 articles were found on the economics of mastitis. Throughout the years, little progress has been made to improve the economic framework regarding production diseases in animal farming, but methodological progress was made in the biological aspect of bioeconomic models. Research focused on the failure costs of mastitis and cost-benefit analyses of cow-level decisions (treatments). The average failure costs of mastitis were $US131 per cow per year. Future economic research should focus more on the utilization of currentlyavailable large databases. The economic framework should be extended toward mastitis as an externality of dairy production (welfare), the externalities of optimal use of chemical and pharmaceutical compounds (antimicrobials), and explaining farmers’ decisions regarding mastitis.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-resource-100518-093954
2019-10-05
2024-06-23
Loading full text...

Full text loading...

/deliver/fulltext/resource/11/1/annurev-resource-100518-093954.html?itemId=/content/journals/10.1146/annurev-resource-100518-093954&mimeType=html&fmt=ahah

Literature Cited

  1. Aghamohammadi M, Haine D, Kelton DF, Barkema HW, Hogeveen H et al. 2018. Herd-level mastitis-associated costs on Canadian dairy farms. Front. Vet. Sci. https://doi.org/10.3389/fvets.2018.00100
    [Crossref] [Google Scholar]
  2. Allore HG, Erb HN. 1998. Partial budget of the discounted annual benefit of mastitis control strategies. J. Dairy Sci. 81:2280–92First Monte Carlo simulation model on economic aspects of mastitis.
    [Google Scholar]
  3. Archer SC, McCoy F, Wapenaar W, Green MJ 2014. Bayesian evaluation of budgets for endemic disease control: an example using management changes to reduce milk somatic cell count early in the first lactation of Irish dairy cows. Prev. Vet. Med. 113:80–87
    [Google Scholar]
  4. Atasever S, Erdem H. 2009. Estimation of milk yield and financial losses related to somatic cell count in Holstein cows raised in Turkey. J. Anim. Vet. Adv. 8:1491–94
    [Google Scholar]
  5. Bar D, Tauer LW, Bennett G, Gonzalez RN, Hertl JA et al. 2008. The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming. J. Dairy Sci. 91:2205–14
    [Google Scholar]
  6. Bar D, Tauer LW, Bennett G, Gonzalez RN, Hertl JA et al. 2009. Use of a dynamic programming model to estimate the value of clinical mastitis treatment and prevention options utilized by dairy producers. Agric. Syst. 99:6–12
    [Google Scholar]
  7. Beck HS, Wise WS, Dodd FH 1992. Cost-benefit analysis of bovine mastitis in the UK. J. Dairy Res. 59:449–60
    [Google Scholar]
  8. Bennett R. 2003. The direct costs of livestock disease: the development of a system of models for the analysis of 30 endemic livestock diseases in Great Britain. J. Agric. Econ. 54:55–71Extensive overview of the economic effects of numerous cattle diseases.
    [Google Scholar]
  9. Bennett R, IJpelaar J. 2005. Updated estimates of the costs associated with thirty four endemic livestock diseases in Great Britain: a note. J. Agric. Econ. 56:135–44
    [Google Scholar]
  10. Berry EA, Hogeveen H, Hillerton JE 2004. Decision tree analysis to evaluate dry cow strategies under UK conditions. J. Dairy Res. 71:409–18
    [Google Scholar]
  11. Carpenter TE. 1993. Veterinary economics—tips, tricks and traps. Prev. Vet. Med. 18:17–31
    [Google Scholar]
  12. Carpenter TE. 1998. Stochastic epidemiologic modelling using a microcomputer spreadsheet package. Prev. Vet. Med. 5:159–68
    [Google Scholar]
  13. Cha E, Bar D, Hertl JA, Tauer LW, Bennett G et al. 2011. The cost and management of different types of clinical mastitis in dairy cows estimated by dynamic programming. J. Dairy Sci. 94:4476–87
    [Google Scholar]
  14. Cha E, Kristensen AR, Hertl JA, Schukken YH, Tauer LW et al. 2014. Optimal insemination and replacement decisions to minimize the cost of pathogen-specific clinical mastitis in dairy cows. J. Dairy Sci. 97:2101–17
    [Google Scholar]
  15. Cha E, Smith RL, Kristensen AR, Hertl JA, Schukken YH et al. 2016. The value of pathogen information in treating clinical mastitis. J. Dairy Res. 83:456–63
    [Google Scholar]
  16. Dahl MO, De Vries A, Maunsell FP, Galvao KN, Risco CA, Hernandez JA 2018. Epidemiologic and economic analyses of pregnancy loss attributable to mastitis in primiparous Holstein cows. J. Dairy Sci. 101:10142–50
    [Google Scholar]
  17. Davis R, Tisdell C. 2002. Alternative specifications and extensions of the economic threshold concept and the control of livestock pests. Economics of Pesticides, Sustainable Food Production, and Organic Food Markets C Darwin, L Hall, J Moffitt 55–79 Bingley, UK: Emerald Group Publ.
    [Google Scholar]
  18. Degraves FJ, Fetrow J. 1993. Economics of mastitis and mastitis control. Vet. Clin. N. Am. Food Anim. Pract. 9:421–34
    [Google Scholar]
  19. Dekkers JCM, Van Erp T, Schukken YH 1996. Economic benefits of reducing somatic cell count under the milk quality program of Ontario. J. Dairy Sci. 79:396–401
    [Google Scholar]
  20. Dijkhuizen AA, Renkema JA, Stelwagen J 1991. Modelling to support animal health control. Agric. Econ. 5:263–77Overview of modeling methods to estimate the economic effects of controlling animal diseases.
    [Google Scholar]
  21. Dillon EJ, Hennessy T, Cullinan J 2015. Measuring the economic impact of improved control of sub-clinical mastitis in Irish dairy herds. J. Agric. Sci. 153:666–75
    [Google Scholar]
  22. Down PM, Bradley AJ, Breen JE, Browne WJ, Kypraios T, Green MJ 2016. A Bayesian micro-simulation to evaluate the cost-effectiveness of interventions for mastitis control during the dry period in UK dairy herds. Prev. Vet. Med. 133:64–72
    [Google Scholar]
  23. Down PM, Bradley AJ, Breen JE, Green MJ 2017. Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows. Prev. Vet. Med. 145:91–99
    [Google Scholar]
  24. Down PM, Green MJ, Hudson CD 2013. Rate of transmission: a major determinant of the cost of clinical mastitis. J. Dairy Sci. 96:6301–14
    [Google Scholar]
  25. El-Tahawy AS, El-Far AH. 2010. Influences of somatic cell count on milk composition and dairy farm profitability. Int. J. Dairy Technol. 63:463–69
    [Google Scholar]
  26. EU (Eur. Union) 2018. EU dairy farms report based on 2016 FADN data Rep., Eur. Union Brussels: https://ec.europa.eu/agriculture/sites/agriculture/files/fadn/documents/dairy-report-2016_en.pdf
    [Google Scholar]
  27. Geary U, Lopez-Villalobos N, Begley N, McCoy F, O'Brien B et al. 2012. Estimating the effect of mastitis on the profitability of Irish dairy farms. J. Dairy Sci. 95:3662–73
    [Google Scholar]
  28. Geary U, Lopez-Villalobos N, O'Brien B, Garrick DJ, Shalloo L 2013. Examining the impact of mastitis on the profitability of the Irish dairy industry. Irish J. Agric. Food Res. 52:135–49
    [Google Scholar]
  29. Getaneh AM, Mekonnen SA, Hogeveen H 2017. Stochastic bio-economic modeling of mastitis in Ethiopian dairy farms. Prev. Vet. Med. 138:94–103
    [Google Scholar]
  30. Gilbert W, Rushton J. 2018. Incentive perception in livestock disease control. J. Agric. Econ. 69:243–61
    [Google Scholar]
  31. Goncalves JL, Kamphuis C, Martins C, Barreiro JR, Tomazi T et al. 2018. Bovine subclinical mastitis reduces milk yield and economic return. Livest. Sci 210:25–32
    [Google Scholar]
  32. Guimarães JLB, Brito MAVP, Lange CC, Silva MR, Ribeiro JB et al. 2017. Estimate of the economic impact of mastitis: a case study in a Holstein dairy herd under tropical conditions. Prev. Vet. Med. 142:46–50
    [Google Scholar]
  33. Gulzari SO, Ahmadi BV, Stott AW 2018. Impact of subclinical mastitis on greenhouse gas emissions intensity and profitability of dairy cows in Norway. Prev. Vet. Med. 150:19–29
    [Google Scholar]
  34. Gussmann M, Kirkeby C, Graesbøll K, Farre M, Halasa T 2018. A strain-, cow-, and herd-specific bio-economic simulation model of intramammary infections in dairy cattle herds. J. Theor. Biol. 449:83–93
    [Google Scholar]
  35. Hadrich JC, Wolf CA, Lombard J, Dolak TM 2018. Estimating milk yield and value losses from increased somatic cell count on US dairy farms. J. Dairy Sci. 101:3588–96
    [Google Scholar]
  36. Hagnestam-Nielsen C, Østergaard S. 2009. Economic impact of clinical mastitis in a dairy herd assessed by stochastic simulation using different methods to model yield losses. Animal 3:315–28
    [Google Scholar]
  37. Halasa T. 2012. Bioeconomic modeling of intervention against clinical mastitis caused by contagious pathogens. J. Dairy Sci. 95:5740–49
    [Google Scholar]
  38. Halasa T, Huijps K, Østerås O, Hogeveen H 2007. Economic effects of bovine mastitis and mastitis management: a review. Vet. Q. 29:18–31Overview of mastitis cost factors.
    [Google Scholar]
  39. Halasa T, Nielen M, Huirne RBM, Hogeveen H 2009a. Stochastic bio-economic model of bovine intramammary infection. Livest. Sci. 124:295–305
    [Google Scholar]
  40. Halasa T, Nielen M, Østerås O, Van Werven T, Hogeveen H 2009b. Meta-analysis of dry cow management for dairy cattle. Part 1. Protection against new intramammary infections. J. Dairy Sci. 92:3134–49
    [Google Scholar]
  41. Halasa T, Nielen M, Van Werven T, Hogeveen H 2010. A simulation model to calculate costs and benefits of dry period interventions in dairy cattle. Livest. Sci. 129:80–87
    [Google Scholar]
  42. Halasa T, Nielen M, Whist AC, Østerås O 2009c. Meta-analysis of dry cow management for dairy cattle. Part 2. Cure of existing intramammary infections. J. Dairy Sci. 92:3150–57
    [Google Scholar]
  43. Heikkila AM, Nousiainen JI, Pyorala S 2012. Costs of clinical mastitis with special reference to premature culling. J. Dairy Sci. 95:139–50
    [Google Scholar]
  44. Hennessy DA, Wolf CA. 2018. Asymmetric information, externalities and incentives in animal disease prevention and control. J. Agric. Econ 69:226–42Good overview on a better understanding of farmers’ behavior beyond utility theory.
    [Google Scholar]
  45. Hillerton JE, West JGH, Shearn MFH 1992. The cost of summer mastitis. Vet. Rec. 131:315–17
    [Google Scholar]
  46. Hogeveen H, Huijps K, Lam T 2011. Economic aspects of mastitis: new developments. N. Z. Vet. J. 59:16–23
    [Google Scholar]
  47. Hogeveen H, Schukken YH, Laporte HM, Noordhuizen JPTM 1993. Cystic ovarian disease in Dutch dairy cattle, II. A simulation model for predicting the herd-level consequences under varying management factors. Livest. Prod. Sci. 38:199–206
    [Google Scholar]
  48. Hogeveen H, Van der Voort M 2017. Assessing the economic impact of an endemic disease: the case of mastitis. Rev. Sci. Tech. Off. Int. Epizoot. 36:217–26Provides a framework to better represent farmers’ decision-making processes and introduces failure costs and prevention costs.
    [Google Scholar]
  49. Hollis A, Ahmed Z. 2013. Preserving antibiotics, rationally. N. Eng. J. Med. 369:2474–76
    [Google Scholar]
  50. Huijps K, De Vliegher S, Lam T, Hogeveen H 2009a. Cost estimation of heifer mastitis in early lactation by stochastic modelling. Vet. Microbiol. 134:121–27
    [Google Scholar]
  51. Huijps K, Hogeveen H. 2007. Stochastic modeling to determine the economic effects of blanket, selective, and no dry cow therapy. J. Dairy Sci. 90:1225–34
    [Google Scholar]
  52. Huijps K, Hogeveen H, Antonides G, Valeeva NI, Lam TJGM, Lansink A 2010a. Sub-optimal economic behaviour with respect to mastitis management. Eur. Rev. Agric. Econ. 37:553–68First study to apply theories from the field of behavioral economics on mastitis.
    [Google Scholar]
  53. Huijps K, Hogeveen H, Lam TJGM, Huirne RBM 2009b. Preferences of cost factors for mastitis management among Dutch dairy farmers using adaptive conjoint analysis. Prev. Vet. Med. 92:351–59
    [Google Scholar]
  54. Huijps K, Hogeveen H, Lam TJGM, Lansink A 2010b. Costs and efficacy of management measures to improve udder health on Dutch dairy farms. J. Dairy Sci. 93:115–24
    [Google Scholar]
  55. Huijps K, Lam TJGM, Hogeveen H 2008. Costs of mastitis: facts and perception. J. Dairy Res. 75:113–20
    [Google Scholar]
  56. Hultgren J, Svensson C. 2009. Lifetime risk and cost of clinical mastitis in dairy cows in relation to heifer rearing conditions in southwest Sweden. J. Dairy Sci. 92:3274–80
    [Google Scholar]
  57. IDF (Int. Dairy Fed.) 2018. The world dairy situation 2018 Bull. 494/2018 Int. Dairy Fed. Brussels: https://store.fil-idf.org/product/bulletin-idf-n-494-2018-world-dairy-situation-2018/
    [Google Scholar]
  58. Jones PJ, Niemi J, Christensen JP, Tranter RB, Bennett RM 2018. A review of the financial impact of production diseases in poultry production systems. Anim. Prod. Sci. https://doi.org/10.1071/AN18281
    [Crossref] [Google Scholar]
  59. Kessels JA, Cha E, Johnson SK, Welcome FL, Kristensen AR, Gröhn YT 2016. Economic comparison of common treatment protocols and J5 vaccination for clinical mastitis in dairy herds using optimized culling decisions. J. Dairy Sci. 99:3838–47
    [Google Scholar]
  60. Kristensen AR. 1987. Hierarchic Markov processes and their applications in replacement models. Eur. J. Oper. Res. 35:207–15
    [Google Scholar]
  61. Kyriazakis I. 2015. Livestock production diseases and European food security. PROHEALTH Blog https://fp7-prohealth.eu/knowledge-platform/newsletter-articles/livestock-production-diseases/
    [Google Scholar]
  62. Lhermie G, Tauer LW, Gröhn YT 2018. The farm cost of decreasing antimicrobial use in dairy production. PLOS ONE 13:e0194832
    [Google Scholar]
  63. Losinger WC. 2005. Economic impact of reduced milk production associated with Johne's disease on dairy operations in the USA. J. Dairy Res. 72:425–32
    [Google Scholar]
  64. McInerney JP. 1996. Old economics for new problems—livestock disease: presidential address. J. Agric. Econ. 47:295–314A key paper presenting the economic framework of animal production diseases.
    [Google Scholar]
  65. McInerney JP, Howe KS, Schepers JA 1992. A framework for the economic analysis of disease in farm livestock. Prev. Vet. Med. 13:137–54
    [Google Scholar]
  66. Mekonnen SA, Koop G, Lam TJGM, Hogeveen H 2017. The intention of North-Western Ethiopian dairy farmers to control mastitis. PLOS ONE 12:e0182727
    [Google Scholar]
  67. Miles H, Lesser W, Sears P 1992. The economic implications of bioengineered mastitis control. J. Dairy Sci. 75:596–605
    [Google Scholar]
  68. Miller GY, Bartlett PC, Lance SE, Anderson J, Heider LE 1993. Costs of clinical mastitis and mastitis prevention in dairy herds. J. Am. Vet. Med. Assoc. 202:1230–36
    [Google Scholar]
  69. Mungube EO, Tenhagen BA, Regassa F, Kyule MN, Shiferaw Y et al. 2005. Reduced milk production in udder quarters with subclinical mastitis and associated economic losses in crossbred dairy cows in Ethiopia. Trop. Anim. Health Prod. 37:503–12
    [Google Scholar]
  70. Murai K, Lehenbauer TW, Champagne JD, Glenn K, Aly SS 2014. Cost-effectiveness of diagnostic strategies using quantitative real-time PCR and bacterial culture to identify contagious mastitis cases in large dairy herds. Prev. Vet. Med. 113:522–35
    [Google Scholar]
  71. Neave FK, Dodd FH, Kingwill RG, Westgarth DR 1969. Control of mastitis in the dairy herd by hygiene and management. J. Dairy. Sci. 52:696–707
    [Google Scholar]
  72. Nielsen C, Østergaard S, Emanuelson U, Andersson H, Berglund B, Strandberg E 2010. Economic consequences of mastitis and withdrawal of milk with high somatic cell count in Swedish dairy herds. Animal 4:1758–70
    [Google Scholar]
  73. Niemi JK, Waret-Szkuta A, Gethmann J, Aragrandem M, Hogeveen H et al. 2014. Current status of economics applied to animal health (EAH): findings from stakeholder and literature surveys Paper presented at the Nordic Assoc. Agric. Sci. Seminar on the Economics of Animal Health and Welfare Hämeenlinna, Finland: Oct. 2–3
    [Google Scholar]
  74. Oliver SP, Lewis MJ, Gillespie BE, Dowlen HH, Jaenicke EC, Roberts RK 2003. Prepartum antibiotic treatment of heifers: milk production, milk quality and economic benefit. J. Dairy Sci. 86:1187–93
    [Google Scholar]
  75. Østergaard S, Chagunda MGG, Friggens NC, Bennedsgaard TW, Klaas IC 2005. A stochastic model simulating pathogen-specific mastitis control in a dairy herd. J. Dairy Sci. 88:4243–57
    [Google Scholar]
  76. Perez-Cabal MA, Yaici S, Alenda R 2008. Clinical mastitis in Spanish dairy cows: incidence and costs. Span. J. Agric. Res. 6:615–22
    [Google Scholar]
  77. Petrovski KR, Trajcev M, Buneski G 2006. A review of the factors affecting the costs of bovine mastitis. J. S. Afr. Vet. Assoc. 77:52–60
    [Google Scholar]
  78. Petzer I-M, Etter EMC, Donkin EF, Webb EC, Karzin J 2017. Epidemiological and partial budget analysis for treatment of subclinical Staphylococcus aureus intramammary infections considering microbiological and cytological scenarios. Prev. Vet. Med. 148:66–77
    [Google Scholar]
  79. Rehman T, McKemey K, Yates CM, Cook RJ, Garforth CJ et al. 2007. Identifying and understanding factors influencing the uptake of new technologies on dairy farms in SW England using the theory of reasoned action. Agric. Syst. 84:281–93
    [Google Scholar]
  80. Rollin E, Dhuyvetter KC, Overton MW 2015. The cost of clinical mastitis in the first 30 days of lactation: an economic modeling tool. Prev. Vet. Med. 122:257–64
    [Google Scholar]
  81. Rougoor CW, Hanekamp WJA, Dijkhuizen AA, Nielen M, Wilmink JBM 1999. Relationships between dairy cow mastitis and fertility management and farm performance. Prev. Vet. Med. 39:247–64
    [Google Scholar]
  82. Ruegg PL, Dohoo IR. 1997. A benefit to cost analysis of the effect of premilking teat hygiene on somatic cell count and intramammary infections in a commercial dairy herd. Can. Vet. J. 38:632–36
    [Google Scholar]
  83. Sasidhar PVK, Reddy YR, Rao BS 2002. Economics of mastitis. Indian J. Anim. Sci. 72:439–40
    [Google Scholar]
  84. Scherpenzeel CGM, den Uiji IEM, Van Schaik G, Riekerink R, Hogeveen H, Lam T 2016. Effect of different scenarios for selective dry-cow therapy on udder health, antimicrobial usage, and economics. J. Dairy Sci. 99:3753–64
    [Google Scholar]
  85. Scherpenzeel CGM, Hogeveen H, Maas L, Lam T 2018. Economic optimization of selective dry cow treatment. J. Dairy Sci. 101:1530–39
    [Google Scholar]
  86. Seegers H, Fourichon C, Beaudeau F 2003. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet. Res. 34:475–91
    [Google Scholar]
  87. Shim EH, Shanks RD, Morin DE 2004. Milk loss and treatment costs associated with two treatment protocols for clinical mastitis in dairy cows. J. Dairy Sci. 87:2702–8
    [Google Scholar]
  88. Sinha MK, Thombare NN, Mondal B 2014. Subclinical mastitis in dairy animals: incidence, economics, and predisposing factors. Sci. World J. 2014:523984
    [Google Scholar]
  89. Sørensen JT, Kristensen ES, Thyssen I 1992. A stochastic model simulating the dairy herd on a PC. Agric. Syst. 39:177–200
    [Google Scholar]
  90. Steeneveld W, Swinkels J, Hogeveen H 2007. Stochastic modelling to assess economic effects of treatment of chronic subclinical mastitis caused by Streptococcus uberis. J. Dairy Res 74:459–67
    [Google Scholar]
  91. Steeneveld W, Van Werven T, Barkema HW, Hogeveen H 2011. Cow-specific treatment of clinical mastitis: an economic approach. J. Dairy Sci. 94:174–88
    [Google Scholar]
  92. Stott AW, Kennedy JOS. 1993. The economics of culling dairy cows with clinical mastitis. Vet. Rec. 133:495–99Presents the first dynamic programming model on optimal cow replacement decisions, including mastitis.
    [Google Scholar]
  93. Swinkels JM, Hogeveen H, Zadoks RN 2005a. A partial budget model to estimate economic benefits of lactational treatment of subclinical Staphylococcus aureus mastitis. J. Dairy Sci. 88:4273–87
    [Google Scholar]
  94. Swinkels JM, Rooijendijk JG, Zadoks RN, Hogeveen H 2005b. Use of partial budgeting to determine the economic benefits of antibiotic treatment of chronic subclinical mastitis caused by Streptococcus uberis or Streptococcus dysgalactiae. J. Dairy Res 72:75–85
    [Google Scholar]
  95. Tesfaye GY, Regassa FG, Kelay B 2010. Milk yield and associated economic losses in quarters with subclinical mastitis due to Staphylococcus aureus in Ethiopian crossbred dairy cows. Trop. Anim. Health Prod. 42:925–31
    [Google Scholar]
  96. Valeeva NI, Lam TJGM, Hogeveen H 2007. Motivation of dairy farmers to improve mastitis management. J. Dairy Sci. 90:4466–77
    [Google Scholar]
  97. Van Arendonk JAM. 1985. Studies on the replacement policies in dairy cattle. II. Optimal policy and influences of changes in production and prices. Livest. Prod. Sci. 13:101–21
    [Google Scholar]
  98. Van den Borne BHP, Halasa T, Van Schaik G, Hogeveen H, Nielen M 2010. Bioeconomic modeling of lactational antimicrobial treatment of new bovine subclinical intramammary infections caused by contagious pathogens. J. Dairy Sci. 93:4034–44
    [Google Scholar]
  99. Van den Borne BHP, Jansen J, Lam TJGM, Van Schaik G 2014. Associations between the decrease in bovine clinical mastitis and changes in dairy farmers’ attitude, knowledge, and behavior in the Netherlands. Res. Vet. Sci. 97:226–29
    [Google Scholar]
  100. Van Eenennaam AL, Gardner IA, Holmes J, Perani L, Anderson RJ et al. 1995. Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. J. Dairy Sci. 78:2086–95
    [Google Scholar]
  101. Van Soest FJS, Abbeloos E, McDougall S, Hogeveen H 2018. Addition of meloxicam to the treatment of bovine clinical mastitis results in a net economic benefit to the dairy farmer. J. Dairy Sci. 101:3387–97
    [Google Scholar]
  102. Van Soest FJS, Santman-Berends IMGA, Lam TJGM, Hogeveen H 2016. Failure and preventive costs of mastitis on Dutch dairy farms. J. Dairy Sci. 99:8365–74
    [Google Scholar]
  103. Waterfield G, Zilberman D. 2012. Pest management in food systems: an economic perspective. Annu. Rev. Environ. Resour. 37:223–45
    [Google Scholar]
  104. Wolfová M, Štípková M, Wolf J 2006. Incidence and economics of clinical mastitis in five Holstein herds in the Czech Republic. Prev. Vet. Med. 77:48–64
    [Google Scholar]
  105. Yalcin C. 2000. Cost of mastitis in Scottish dairy herds with low and high subclinical mastitis problems. Turk. J. Vet. Sci. 24:465–72
    [Google Scholar]
  106. Yalcin C, Stott AW. 2000. Dynamic programming to investigate financial impacts of mastitis control decisions in milk production systems. J. Dairy Res. 67:515–28
    [Google Scholar]
  107. Yalcin C, Stott AW, Logue DN, Gunn J 1999. The economic impact of mastitis-control procedures used in Scottish dairy herds with high bulk-tank somatic-cell counts. Prev. Vet. Med. 41:135–49First study to estimate the total costs of mastitis (failure costs plus prevention costs).
    [Google Scholar]
  108. Zepeda L, Buelow KL, Nordlund KV, Thomas CB, Collins MT, Goodger WJ 1998. A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis. Prev. Vet. Med. 33:183–93
    [Google Scholar]
/content/journals/10.1146/annurev-resource-100518-093954
Loading
/content/journals/10.1146/annurev-resource-100518-093954
Loading

Data & Media loading...

Supplementary Data

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error